Opportunities and challenges of proteomics in pediatric patients: Circulating biomarkers after hematopoietic stem cell transplantation as a successful example-Reference-Cited by-同舟云学术

Opportunities and challenges of proteomics in pediatric patients: Circulating biomarkers after hematopoietic stem cell transplantation as a successful example

Published:2014-10-30 Issue:11-12 Volume:8 Page:837-850
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Paczesny Sophie¹,Duncan Christine²,Jacobsohn David³,Krance Robert⁴,Leung Kathryn⁴,Carpenter Paul⁵,Bollard Catherine³⁶,Renbarger Jamie¹,Cooke Kenneth⁷

Affiliation:

1. Department of Pediatrics; Indiana University School of Medicine; Indianapolis IN USA

2. Boston Children's Hospital; Boston MA USA

3. Children's National Medical Center; Washington, DC USA

4. Texas Children's Hospital; Houston TX USA

5. Fred Hutchinson Cancer Research Center; Seattle WA USA

6. Department of Pediatrics; George Washington University; Washington, DC USA

7. Department of Pediatrics; Johns Hopkins University School of Medicine; Baltimore MD USA

Funder

Eunice Kennedy Shriver National Institute of Child Health & Human Development

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201400033/fullpdf

Reference108 articles.

1. New perspectives on the biology of acute GVHD;Paczesny;Bone Marrow Transplant.,2010

2. Biomarkers Definitions Working Group, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Clin. Pharmacol. Ther.,2001

3. The uses of biomarkers in drug development;Hurko;Annal. NY Acad. Sci.,2009

4. Toward a standardized urine proteome analysis methodology;Court;Proteomics,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1;Scandinavian Journal of Clinical and Laboratory Investigation;2019-02-06

2. Graft-versus-host disease in children after hematopoietic cell transplantation: potential clinical utility of biomarkers;International Journal of Hematologic Oncology;2015-04

3. Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation;Frontiers in Immunology;2015-01-28

4. Paediatrics and proteomics: Back to the beginning;PROTEOMICS - Clinical Applications;2014-12